APOTHEEK BERDEN
ActiveSummary
APOTHEEK BERDEN has been active since 2013 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €611k and a net result of €112k. Equity is growing by ~13.8% per year across the filed fiscal years. Its solvency ranks better than 68% of 10359 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.6% (low).
Checked score
Score 2025
73
/ 100
Healthy
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability82▼-6
Solvency81▲+4
Growth78=
Track record100
Bankruptcy probability, 12 months
0.6%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €40k at 30 days acceptable
Liquidity ample (current ratio 2.3 against 2.15 in 2024; short-term debt: 39.7% and cash: 20.2% of total assets), and 44.3% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Four signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
55.7%
Return on assets
10.3%
Age of the figures
9 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 03-06-2026, 58 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
58 d early
2024
58 d early
2023
28 d early
2022
6 d early
2021
5 d early
2020
17 d late
2019
88 d late
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
24-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, abbreviated schema
Equity
€611k▲ 13.0%
2024 · €541k
2018: €246k
2019: €288k
2020: €292k
2021: €340k
2022: €434k
2023: €555k
2024: €541k
2018 → 2025
Total assets
€1.10M▲ 5.0%
2024 · €1.04M
2018: €872k
2019: €799k
2020: €746k
2021: €758k
2022: €789k
2023: €953k
2024: €1.04M
2018 → 2025
Net result
€112k▼ 29.8%
2024 · €160k
2018: €57k
2019: €42k
2020: €61k
2021: €49k
2022: €94k
2023: €121k
2024: €160k
2018 → 2025
Working capital
€564k▲ 13.8%
2024 · €496k
2018: €-29k
2019: €30k
2020: €87k
2021: €201k
2022: €364k
2023: €546k
2024: €496k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€340k-€434k▲ 27.5%€555k▲ 27.8%€541k▼ 2.5%€611k▲ 13.0%
Operating result€38k-€96k▲ 150%€126k▲ 31.5%€248k▲ 96.6%€182k▼ 26.6%
Net result€49k-€94k▲ 92.9%€121k▲ 28.7%€160k▲ 32.8%€112k▼ 29.8%
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 27% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.10M
Fixed assets
€97k ▼ 17.0%
Current assets
€1,000k ▲ 7.8%
Equity and liabilities €1.10M
Equity
€611k ▲ 13.0%
Debt
€485k ▼ 3.5%
Debt's share of the balance-sheet total falls from 48.2% to 44.3%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€212k▼
2024 · €274k
Cash flow
€142k▼
2024 · €187k
Current ratio
2.30▲
2024 · 2.15
Quick ratio
1.94▲
2024 · 1.71
Debt to equity
0.79▼
2024 · 0.93
ROE
18.4%▼
2024 · 29.6%
ROA
10.3%▼
2024 · 15.4%
Interest coverage
8.04▼
2024 · 9.43
Debt ≤ 1 year
€435k▲
2024 · €431k
Debt > 1 year
€47k▼
2024 · €67k
Income taxes
€48k▼
2024 · €71k
Staff costs
€149k▲
2024 · €125k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 55 lines
Balance sheet
Code20242025
Assets
Total assets20/58€1.04M€1.10M▲
Fixed assets21/28€116k€97k▼
Tangible fixed assets22/27€116k€90k▼
Land and buildings22€2k€534▼
Plant, machinery and equipment23€4k€4k▲
Furniture and vehicles24€110k€85k▼
Financial fixed assets28-€7k
Current assets29/58€927k€1,000k▲
Stocks and contracts in progress3€192k€155k▼
Stocks30/36€192k€155k▼
Amounts receivable within one year40/41€100k€104k▲
Trade receivables40€100k€104k▲
Other amounts receivable41€111€0▼
Current investments50/53€300k€500k▲
Cash at bank and in hand54/58€307k€221k▼
Deferred charges and accrued income490/1€28k€19k▼
Equity and liabilities
Total equity and liabilities10/49€1.04M€1.10M▲
Equity10/15€541k€611k▲
Contributions10/11€12k€12k=
Reserves13€528k€599k▲
Distributable reserves133€528k€599k▲
Profit (loss) carried forward14€0€0=
Amounts payable17/49€503k€485k▼
Amounts payable after more than one year17€67k€47k▼
Financial debts170/4€67k€47k▼
Amounts payable within one year42/48€431k€435k▲
Current portion of amounts payable after more than one year42€19k€20k▲
Trade debts44€81k€78k▼
Suppliers440/4€81k€78k▼
Taxes, remuneration and social security45€51k€45k▼
Taxes450/3€29k€20k▼
Remuneration and social security454/9€21k€25k▲
Other amounts payable47/48€281k€293k▲
Accrued charges and deferred income492/3€5k€3k▼
Income statement
Code20242025
Non-recurring operating income76A€0-
Remuneration, social security and pensions62€125k€149k▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€26k€30k▲
Other operating charges640/8€1k€5k▲
Gross operating margin9900€401k€366k▼
Operating profit (loss)9901€248k€182k▼
Financial income75/76B€12k€5k▼
Recurring financial income75€12k€5k▼
Financial charges65/66B€29k€26k▼
Recurring financial charges65€29k€26k▼
Profit (loss) for the period before taxes9903€231k€161k▼
Income taxes67/77€71k€48k▼
Profit (loss) for the period9904€160k€112k▼
Profit (loss) for the period to be appropriated9905€160k€112k▼
Appropriation of the result
Profit (loss) to be appropriated9906€160k€112k▼
Transfer from equity791/2€174k€42k▼
Transfer to equity691/2€160k€112k▼
To other reserves6921€160k€112k▼
Profit to be distributed694/7€174k€42k▼
Return on contributions (dividend)694€174k€42k▼
Social balance
Average headcount (FTE)90872.12.5▲
The notes to these accounts (15 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
03-06
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema
2025
03-06
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema
2024
31-12
Financial
Highest result since 2018net €160k ▲32.8%
Operating result €248k, net result €160k, both a record.
03-07
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema
2023
31-12
Financial
Equity above €500kEq €555k ▲27.8%
6 profitable years in a row build equity to €555k.
25-07
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema
2022
26-07
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema
2021
17-08
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema · 17 days late
2020
27-10
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema · 88 days late
2019
31-12
Financial
Weakest financial yearnet €42k ▼26.2%
Net result drops to €42k, the lowest in the series; recovery starts the following year.
27-08
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema · 27 days late
2018
25-07
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema
2017
10-08
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema · 10 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Landen · 1 establishment unit since 2013
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Gordelstraat 913401 LandenGround area
2,410 m²
Building footprint
403 m²
Volume, LiDAR
1,993 m³
2 parcels, Flanders · tallest building 13.9 m, ±4 floors. Linked by address, not a title deed.
1 establishment unit
APOTHEEK BERDEN
since 20132.224.487.340
2 parcels
Flanders
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 24118A1390/00B000 | Flanders | 2,175 m² | 1 · 212 m² | 0.4 m |
| 71053H1224/00B000 | Flanders | 235 m² | 1 · 191 m² | 13.9 m · 4 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
1 of these parcels carry protected heritage (source: regional heritage registers, Onroerend Erfgoed / patrimoine.brussels).
Public money · subsidies and aid
Flemish government
2023 · 1 entry · 2,000 EUR awarded · 2,000 EUR paid| Year | Entries | awarded | paid |
|---|---|---|---|
| 2023 | 1 | 2,000 EUR | 2,000 EUR |
Schemes
Hinderpremie bij openbare werken
Recognitions · licences · registrations
Food safety, FASFC
1 siteSint-Truiden2.224.487.340
Similar companies · same sector, comparable size
MOBIPHAR
BE 0824.257.894
Zedelgem · Eq €611,817
APOTHEEK RAUW
BE 0417.385.357
Mol · Eq €609,818
PHARMA COVA
BE 0826.853.833
Antwerpen · Eq €612,382
APOTHEEK KEYMOLEN
BE 0456.560.291
Vilvoorde · Eq €609,586
APOTHEEK PLATTEEUW B
BE 0478.986.889
Ronse · Eq €612,925
Of 5,220 companies in sector 47730 we hold annual accounts for 3,861. 3,285 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded05-12-2013
Fiscal year end31-12
Activities, NACEBEL 2025
47730Retail sale of pharmaceutical products
Sources
Crossroads Bank for EnterprisesNational Bank · 12 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.